"Acute Coronary Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Descriptor ID |
D054058
|
| MeSH Number(s) |
C14.280.647.124 C14.907.585.124
|
| Concept/Terms |
Acute Coronary Syndrome- Acute Coronary Syndrome
- Acute Coronary Syndromes
- Coronary Syndrome, Acute
- Coronary Syndromes, Acute
- Syndrome, Acute Coronary
- Syndromes, Acute Coronary
|
Below are MeSH descriptors whose meaning is more general than "Acute Coronary Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Acute Coronary Syndrome".
This graph shows the total number of publications written about "Acute Coronary Syndrome" by people in this website by year, and whether "Acute Coronary Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 8 | 0 | 8 |
| 2008 | 7 | 2 | 9 |
| 2009 | 18 | 1 | 19 |
| 2010 | 8 | 1 | 9 |
| 2011 | 13 | 0 | 13 |
| 2012 | 8 | 0 | 8 |
| 2013 | 25 | 1 | 26 |
| 2014 | 13 | 0 | 13 |
| 2015 | 12 | 1 | 13 |
| 2016 | 16 | 0 | 16 |
| 2017 | 6 | 4 | 10 |
| 2018 | 4 | 2 | 6 |
| 2019 | 5 | 0 | 5 |
| 2020 | 4 | 1 | 5 |
| 2021 | 3 | 0 | 3 |
| 2022 | 9 | 0 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acute Coronary Syndrome" by people in Profiles.
-
Survival After Invasive or Conservative Management of Stable Coronary Disease. Circulation. 2023 01 03; 147(1):8-19.
-
Biomarker-Based Prediction of Recurrent?Ischemic Events in Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2022 11 01; 80(18):1735-1747.
-
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes. J Clin Lipidol. 2022 Sep-Oct; 16(5):747-756.
-
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. Circulation. 2022 Aug 30; 146(9):657-672.
-
Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial. Eur Heart J Acute Cardiovasc Care. 2022 Jun 07; 11(4):336-349.
-
Clinician Perception of Risk As a Barrier to Implementation of a High-sensitivity Troponin Accelerated Diagnostic Protocol. Crit Pathw Cardiol. 2022 06 01; 21(2):73-76.
-
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial. Am J Med. 2022 07; 135(7):915-918.
-
Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndrome. Coron Artery Dis. 2022 08 01; 33(5):376-384.
-
Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA. 2022 Feb 15; 327(7):662-675.
-
Feasibility and Impact of the Combined Application of Coronary CT Angiography With the HEART Pathway in Patients With Suspected Acute Coronary Syndrome. Crit Pathw Cardiol. 2021 12 01; 20(4):185-191.